comparemela.com

Latest Breaking News On - Abhay gandhi - Page 1 : comparemela.com

Sun Pharma to pursue M&A, licensing to expand speciality business

Sun Pharma to pursue M&A, licensing to expand speciality business
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Mumbai
Maharashtra
India
United-states
America
Sun-pharma
Abhay-gandhi
North-america-business
Taro-pharmaceutical-industrie
Expand-speciality
Concert-pharma

Sun Pharma: Sun Pharma clocks $1bn sales in FY24 | Delhi News

Sun Pharma: Sun Pharma clocks $1bn sales in FY24 | Delhi News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Madras
Tamil-nadu
India
Japan
Israel
Ashok-jhunjhunwala
Dilip-shanghvi
Abhay-gandhi
Sun-pharma
Edusa-pharmaceuticals
Madras-research-park
Taro-pharma

Blindwink India Design Awards 2023 Winners Announced

Blindwink - India Design Awards 2023, honoured the creative brilliance of Architects & Interior Designers with  Ar. Krishna Rao Jaisim &  celebrity Amrita Rao as Chief - by estudiosiete@protonmail.com

Hyderabad
Andhra-pradesh
India
Kerala
Kanpur
Uttar-pradesh
Ahmednagar
Maharashtra
Uttarakhand
Uttaranchal
Bangalore
Karnataka

Sun Pharma announces US FDA Filing Acceptance of New Drug Application For Deuruxolitinib

Sun Pharma announces US FDA Filing Acceptance of New Drug Application For Deuruxolitinib
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United-states
American
America
Sun-pharma
Nicole-friedland
Abhay-gandhi
National-alopecia-areata-foundation
Venereology-congress
American-academy-of-dermatology
Sun-pharmaceutical-industries
Sun-pharmaceutical-industries-ltd-reuters
Drug-administration

usfda: Sun Pharma files new drug application with USFDA for investigational medicine to treat alopecia

The new drug application filing for deuruxolitinib with the USFDA is based on two pivotal Phase III trials, which included over 1,200 patients, across more than 135 clinical trial sites, the company said.

Kozhikode
Kerala
India
United-states
America
American
Sun-pharma
Abhay-gandhi
Offering-college
Sun-pharmaceutical-industries-ltd-on
Venereology-congress
Healthcare-management-analytics-programme

vimarsana © 2020. All Rights Reserved.